-
1
Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
Published 2025-01-01Subjects: “…NSCLC…”
Get full text
Article -
2
-
3
-
4
Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy
Published 2025-02-01Subjects: Get full text
Article -
5
Responsive afatinib treatment in high-grade salivary gland ductal carcinoma and NSCLC with uncommon EGFR mutations: Treatment outcomes
Published 2024-06-01Subjects: “…NSCLC…”
Get full text
Article -
6
AMPK: An energy sensor for non-small cell lung cancer progression and treatment
Published 2025-02-01Subjects: Get full text
Article -
7
Safety of brigatinib following alectinib-induced-pneumonitis: Case report
Published 2025-01-01Subjects: Get full text
Article -
8
Circulating Tumor DNA Detection for Recurrence Monitoring of Stage I Non‐Small Cell Lung Cancer Treated With Microwave Ablation
Published 2025-01-01Subjects: Get full text
Article -
9
Unveiling the immunomodulatory dance: endothelial cells’ function and their role in non-small cell lung cancer
Published 2025-01-01Subjects: “…NSCLC…”
Get full text
Article -
10
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
Published 2024-03-01Subjects: Get full text
Article -
11
Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors
Published 2025-01-01Subjects: Get full text
Article -
12
Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR
Published 2025-01-01Subjects: Get full text
Article -
13
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator’s Consortium Registry Analysis
Published 2025-01-01Subjects: “…EGFR NSCLC…”
Get full text
Article -
14
Sotorasib resistance triggers epithelial-mesenchymal transition and activates AKT and P38-mediated signaling
Published 2025-01-01Subjects: Get full text
Article -
15
Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer
Published 2025-01-01Subjects: Get full text
Article -
16
Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC
Published 2025-01-01Subjects: Get full text
Article -
17
Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study
Published 2025-01-01Subjects: Get full text
Article -
18
LRP1 involvement in FHIT-regulated HER2 signaling in non-small cell lung cancer
Published 2025-03-01Subjects: “…NSCLC…”
Get full text
Article -
19
Diagnostic role of circulating long non-coding RNA LINC00312 in patients with non-small cell lung cancer: a retrospective study
Published 2025-01-01Subjects: “…NSCLC…”
Get full text
Article -
20
Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience
Published 2025-01-01Subjects: Get full text
Article